Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature.
about
Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer TherapyIncidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysisRegulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservationTargeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategiesBortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis.Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.Proteasomal and lysosomal protein degradation and heart disease.Cardiomyocyte autophagy and cancer chemotherapy.Degradation of a connexin40 mutant linked to atrial fibrillation is accelerated.A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myelomaVentricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database.Immunoglobulin light chain amyloidosis.Echocardiography in cardiac amyloidosis.Ubiquitin and ubiquitin-like proteins in cardiac disease and protection.A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.Comprehensive review on cardio-oncology: Role of multimodality imaging.Safety of proteasome inhibitors for treatment of multiple myeloma.Bortezomib-dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study.Short- and long-term outcomes of AL amyloidosis patients admitted into intensive care units.Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy.Repeated intermittent administration of a ubiquitous proteasome inhibitor leads to restrictive cardiomyopathy.Docetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular Fibrosis.The proteasome and proteasome inhibitors in multiple myeloma.Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies.Cardiovascular complications of multiple myeloma in the elderly.Bortezomib-Induced Cardiac Tamponade in a 49-Year-Old ManEmergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
P2860
Q26797138-82A49858-7602-4617-8010-D5BDF4901C67Q26991817-0159226B-8627-4CB2-BC7F-475C63BDA4D2Q27000202-D7415E73-FD3E-466C-BCCE-01D87044E881Q27026951-0EE4068E-02F3-4DF2-9928-D9033933E424Q33417805-E6B64E14-4524-4A92-B85E-71403E8801D2Q33427726-2BAAB8FA-2E9E-4C78-8EDD-B8EE338F4812Q33573707-C3770A7C-3481-44E5-900D-AA3FA890F21BQ33573823-17A9A6F5-751E-45E7-B47E-84FFC8ED358FQ34055972-D250B6FC-3F16-4CF6-8182-B4057E45E79BQ36671445-F654C90C-939A-43D3-BCF6-5485D93B4D3DQ37247207-7F87BA7D-8E82-4FF3-8C8E-9BB6044B26F4Q38115568-A271A71D-DD82-48EC-B88E-00B59040507EQ38172295-5BBBA3BA-73B1-4B46-95EF-B168AE91EC1BQ38322136-80C6FA10-C706-4871-B092-5671C1FCAB3BQ38663141-034AE078-6029-49F6-BE01-DCDB707052B3Q38807562-9D7C249C-F386-4703-BBEB-0B7871849A5EQ38844387-E99D799D-CEC4-4C7A-8004-E42D127EA46EQ39007504-704F8BC2-D85B-401D-9387-83A58D2A02B6Q40480703-4B0C4A1C-CAA4-4A27-9D9D-5B4B44B77E08Q40705462-7341838A-E83D-4AC1-9E27-C0259AC20924Q41825817-DFA3DBE8-575D-42EB-AF56-222E1784E7D0Q43154485-2824C0B8-5DE1-40B3-BE4D-444088482EC9Q46547122-A102B943-4981-4699-8F75-B6181621BAC3Q47339695-EE010068-494B-40FF-A731-DB8136D8B91DQ47364092-4C27F63D-0C11-428A-9F7F-91B26DF2E114Q47374630-AB3FA116-4311-420E-8F46-9ACA81A14A09Q58130392-A7BC1F11-EF8B-481B-9D6B-D0D4CBDD670EQ58728912-E7BF449A-FDAA-4235-A72B-49DE494789E7
P2860
Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Severe heart failure after bor ...... and review of the literature.
@en
type
label
Severe heart failure after bor ...... and review of the literature.
@en
prefLabel
Severe heart failure after bor ...... and review of the literature.
@en
P2093
P2860
P356
P1433
P1476
Severe heart failure after bor ...... and review of the literature.
@en
P2093
Bruno Bockorny
Margarita Bockorny
Peter Schulman
Robert Bona
Saneka Chakravarty
P2860
P304
P356
10.1159/000340050
P577
2012-09-04T00:00:00Z